Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 16 Oct 2026 for MapLight Therapeutics, Inc., €73k. Read the official filing
Filing timeline
BuySaleJonathan Gillis
Insider track record
Disclosed buys
0
Disclosed sells
14
Signal history
Jonathan Gillis: trading record in brief
Jonathan Gillis discloses dealings in MapLight Therapeutics, Inc. to SEC (Form 4). In total, 19 filings cover trades dated from 27 October 2025 to 15 October 2026.
Every open-market trade on record is a sale: 14 sales worth €3.1M. The rest of the record consists of 5 share grants. In 2026 alone, the filings show no purchases and 14 sales.
The record was last updated on 16 October 2026 with an open-market sale (€73k) in MapLight Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jonathan Gillis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
10,167 shares@ US$8.08Voting Common StockSEC:0001709954-26-000014:0
6,020 shares0Voting Common StockSEC:0001709954-26-000012:0
2,222 shares0Voting Common StockSEC:0001709954-26-000012:1
5,356 shares@ US$36.130.032% mcap5.0% of flowVoting Common StockSEC:0001709954-26-000010:0
4,699 shares@ US$36.940.029% mcap4.5% of flowVoting Common StockSEC:0001709954-26-000010:1
6,979 shares@ US$36.660.042% mcap6.6% of flowVoting Common StockSEC:0001709954-26-000010:2
1,476 shares@ US$37.440.0092% mcap1.4% of flowVoting Common StockSEC:0001709954-26-000010:3
16,969 shares@ US$37.610.11% mcap16.4% of flowVoting Common StockSEC:0001709954-26-000010:5
900 shares@ US$38.170.0057% mcap0.9% of flowVoting Common StockSEC:0001709954-26-000010:6
600 shares@ US$36.510.0036% mcap0.6% of flowVoting Common StockSEC:0001709954-26-000010:4
7,914 shares@ US$28.940.044% mcap5.8% of flowVoting Common StockSEC:0001709954-26-000008:0
29,623 shares@ US$29.600.17% mcap22.0% of flowVoting Common StockSEC:0001709954-26-000008:1
14,363 shares@ US$30.460.084% mcap11.0% of flowVoting Common StockSEC:0001709954-26-000008:2
17,235 shares@ US$30.330.100% mcap13.1% of flowVoting Common StockSEC:0001709954-26-000008:3
700 shares@ US$30.830.0041% mcap0.5% of flowVoting Common StockSEC:0001709954-26-000008:4
3,590 shares@ US$26.610.018% mcap2.4% of flowVoting Common StockSEC:0001709954-26-000006:0
6,020 shares0Voting Common StockSEC:0001709954-26-000004:0
22,050 shares@ US$17.989.8% of flowVoting Common StockSEC:0001709954-26-000002:0
30,565 shares0Voting Common StockSEC:0001709954-25-000007:0
19 of 19 declarations
